Boswellia
The Indian herb boswellia has been shown in clinical trials to be as effective as conventional drugs for rheumatoid arthritis (RA) pain. India’s Council for Scientific and Industrial Research undertook a series of studies to find herbal-based anti-inflammatory products with beneficial effects on rheumatic diseases without side effects. They concluded that boswellic acids, the active constituents in boswellia, are more potent and less toxic than standard NSAIDs. Boswellic acids are thought to be analgesic and to reduce the production of inflammatory chemicals (leukotrienes). In a comparative study involving 175 rheumatoid arthritis patients, 97 per cent reported moderate to excellent improvements in pain, joint swelling and morning stiffness after taking 450 to 750 mg of boswellic acids daily for three to four weeks. These results equalled those for patients taking the conventional drugs ketoprofen and phenylbutazone, but unlike the drug treatments boswellic acids caused no undesirable side effects. As well as supplements, boswellia is available as a cream for topical application.













